Multivalent Vaccine Composition

Abstract: The present invention pertains to a multivalent vaccine formulation comprising at least one inactivated poliovirus (IPV) S19 strain selected from S19 Type 1, S19 Type 2 and S19 Type 3 and at least one antigen selected from Diphtheria toxoid (DT), Tetanus toxoid (TT), whole-cell Bordetella pertussis (wP), acellular Pertussis (aP), Hepatitis B surface protein, Haemophilus influenzae Type b polysaccharide, Inactivated Japanese encephalitis (JE) virus and Inactivated Rotavirus 116E strain (IRV). The multivalent vaccine formulation of the present invention provide protection against several diseases, simplify vaccine administration and improve vaccine compliance.

Patent Information

Application #

Filing Date

12 February 2019

Publication Number

33/2020

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

hyderabad@knspartners.com

Parent Application

Applicants

BIOLOGICAL E LIMITED

18/1 & 3, Azamabad, Hyderabad, Telangana, India, Pin Code-500 020.

Inventors

1. SIVAKUMAR AYYASWAMY PERNAMALLUR

Biological E. Ltd., Plot No. 18/1 & 3, Azamabad, Hyderabad, Telangana, India, Pin Code-500 020.

2. VIKRAM MADHUSADAN PARADKAR

Biological E. Ltd., Plot No. 18/1 & 3, Azamabad, Hyderabad, Telangana, India, Pin Code-500 020.

3. NARENDER DEV MANTENA

Biological E. Ltd., Plot No. 18/1 & 3, Azamabad, Hyderabad, Telangana, India, Pin Code-500 020.

4. MAHIMA DATLA

Biological E. Ltd., Plot No. 18/1 & 3, Azamabad, Hyderabad, Telangana, India, Pin Code-500 020.

Specification

DESC:Please refer the attached complete specification ,CLAIMS:Please refer the attached complete specification

Documents

Application Documents

#	Name	Date
1	201841042715-STATEMENT OF UNDERTAKING (FORM 3) [12-11-2018(online)].pdf	2018-11-12
2	201841042715-PROVISIONAL SPECIFICATION [12-11-2018(online)].pdf	2018-11-12
3	201841042715-FORM 1 [12-11-2018(online)].pdf	2018-11-12
4	201841042715-DECLARATION OF INVENTORSHIP (FORM 5) [12-11-2018(online)].pdf	2018-11-12
5	201841042715-FORM-26 [21-11-2018(online)].pdf	2018-11-21
6	Correspondence by Agent_Power of Attorney_26-11-2018.pdf	2018-11-26
7	201841042715-Proof of Right (MANDATORY) [21-12-2018(online)].pdf	2018-12-21
8	Correspondence by Agent_Form1_26-12-2018.pdf	2018-12-26
9	201841042715-PostDating-(22-10-2019)-(E-6-281-2019-CHE).pdf	2019-10-22
10	201841042715-APPLICATIONFORPOSTDATING [22-10-2019(online)].pdf	2019-10-22
11	201841042715-CORRESPONDENCE-OTHERS [12-02-2020(online)].pdf	2020-02-12
12	201841042715-COMPLETE SPECIFICATION [12-02-2020(online)].pdf	2020-02-12
13	201841042715-Request Letter-Correspondence [20-02-2020(online)].pdf	2020-02-20
14	201841042715-Power of Attorney [20-02-2020(online)].pdf	2020-02-20
15	201841042715-Form 1 (Submitted on date of filing) [20-02-2020(online)].pdf	2020-02-20
16	201841042715-ENDORSEMENT BY INVENTORS [18-03-2020(online)].pdf	2020-03-18
17	201841042715-FORM 18 [23-08-2022(online)].pdf	2022-08-23
18	201841042715-PRE GRANT OPPOSITION FORM [03-10-2024(online)].pdf	2024-10-03
19	201841042715-PRE GRANT OPPOSITION DOCUMENT [03-10-2024(online)].pdf	2024-10-03
20	201841042715-FORM-26 [04-10-2024(online)].pdf	2024-10-04
21	201841042715-FORM 3 [21-03-2025(online)].pdf	2025-03-21
22	201841042715-PRE GRANT OPPOSITION FORM [22-07-2025(online)].pdf	2025-07-22
23	201841042715-PRE GRANT OPPOSITION DOCUMENT [22-07-2025(online)].pdf	2025-07-22
24	201841042715-FORM-26 [06-08-2025(online)].pdf	2025-08-06